Deric Rachjaibun
Family Medicine · Northglenn, CONPI 1902903933
Payments from drug & device makers
Across 102 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$653
- Lilly USA, LLC$245
- Idorsia Pharmaceuticals US Inc$215
- Novo Nordisk$206
- Boston Scientific$193
- Johnson & Johnson$160
- plus $611 from 12 others
What the payments were for
- Food & beverage$2,27199%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $653 |
| Lilly USA, LLC | 15 | $245 |
| Idorsia Pharmaceuticals US Inc | 12 | $215 |
| Novo Nordisk | 12 | $206 |
| Boston Scientific | 1 | $193 |
| Johnson & Johnson | 2 | $160 |
| Ardelyx, Inc. | 2 | $137 |
| Bausch Health US, LLC | 8 | $135 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $73 |
| GSK | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Eisai Inc. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Pfizer | 1 | $20 |
| Abbott | 1 | $19 |
| Lundbeck LLC | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,282 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 46 | $49,028 |
| AplenzinBupropion Hbr | 12 | $32,480 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $31,523 |
| FarxigaDapagliflozin Propanediol | 27 | $25,700 |
| OzempicSemaglutide | 17 | $25,566 |
| TrulicityDulaglutide | 16 | $17,604 |
| LinzessLinaclotide | 32 | $17,566 |
| JardianceEmpagliflozin | 15 | $9,121 |
| Levemir FlexpenInsulin Detemir | 11 | $4,674 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 66 | $1,110 |
| Gabapentin | 58 | $896 |
| Triazolam | 12 | $686 |
| Omeprazole | 54 | $625 |
| Losartan Potassium | 49 | $620 |
| Levothyroxine Sodium | 79 | $558 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $245 | $66,63262 claims |
| Bausch Health US, LLCAplenzin | $135 | $32,48012 claims |
| GSKTrelegy Ellipta | $70 | $31,52328 claims |
| AstraZenecaFarxiga | $653 | $25,70027 claims |
| Novo NordiskOzempic | $206 | $25,56617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Northglenn
- Larry DoehringNorthglenn$64K
- Matthew MorganNorthglenn$45K
- David ParkerNorthglenn$44K
- Joseph LovatoNorthglenn$21K
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Ripley HollisterColorado Springs$5.5M
- Timothy ColanderAurora$3.1M
- Mia ScottDenver$993K
- Matthew LewisAurora$960K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.